Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South AfricaArticle Published on 2022-10-012022-11-16 Journal: The Lancet. Microbe [Category] COVID19(2023년), SARS, 변종, [키워드] African age agency aggregate analyses Analysis assessment calculate case ascertainment characterisation Characteristics correlation coefficient COVID-19 data-driven death dependent on develop disease severity Effect epidemic wave epidemiological estimate fluctuation Government Hospital admission hospitalisation hospitalisations individual information interval laboratory data Metrics Older Omicron variant pathogen Population provide public health Public health responses reduced reduction in resource responses robust SARS-CoV-2 severity South South Africa Spread surveillance data variant VoC VOCs [DOI] 10.1016/S2666-5247(22)00182-3 PMC 바로가기
Global Vaccine Inequality Threatens to Unleash the Next COVID-19 VariantMini review Published on 2022-10-012022-10-05 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] adopted B.1.1.529 B.1.617.2 booster doses country COVID-19 COVID-19 infection delta variant dominant Europe Healthcare disparity inequality lowest omicron pandemic persistence Prevent Region South Africa strain the United State The United States vaccination rate Vaccine vaccine availability Vaccines variant variants virus [DOI] 10.1016/j.ijid.2022.08.010 [Article Type] Mini review
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review오미크론의 분자적 측면, 백신 개발 및 재조합 균주 XE: 검토Review Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] ACE2 affinity antibody resistance B.1.1.529 booster Booster vaccine COVID-19 CRISPR decrease dosage Efficiency elicited epidemiological Evolution feature genomic global pandemic Infection Mutation omicron Omicron variant Prevalence rate of infection RBD region recombinant variants reduce Research research and development several variant several variants South Africa specific mutations spike region strain T-cell immunity Transmission utilization Vaccine Vaccine development Vaccines variant variant of COVID-19. variant-specific vaccine variant-specific vaccines virus with COVID-19 [DOI] 10.1002/jmv.27936 PMC 바로가기 [Article Type] Review
Impact of the COVID-19 pandemic on the South African tobacco and alcohol industries: Experiences from British American Tobacco and Distell Group LimitedResearch article Published on 2022-10-012022-10-05 Journal: Physics and Chemistry of the Earth, Parts A/B/C [Category] 진단, [키워드] African alcohol British American Tobacco COVID-19 COVID-19 pandemic determine DGH disaster Distell group holding Effect experience Google Finance group Impact Limited Local lockdown long-lasting mitigate Policy promote reduced Share price South South Africa state stock Support Test utilised viability widespread [DOI] 10.1016/j.pce.2022.103186 [Article Type] Research article
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?Review Published on 2022-10-012022-10-06 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, [키워드] ACE-2 analyzed Angiotensin converting enzyme-2 B.1.1.529 catastrophic circulating contagious COVID-19 COVID-19 cases COVID-19 pandemic detrimental dissemination dominant Efficacy effort Evolution explained feasible feature FIVE Genetic hazard host receptor immune evasion immunization implication include Lineage Measures mechanism Mutation omicron Omicron variant other variant pandemic pharmacological physical Population prevalent strain raise RBD reported S-protein SARS-CoV-2 South Africa spike mutation Spread Sublineages surpassed Surveillance susceptible the receptor-binding domain the spike protein United Kingdom Vaccine vaccine effectiveness variant variants of concern variants of SARS-CoV-2 variants. viral entry VoC VOCs [DOI] 10.1016/j.biopha.2022.113522 PMC 바로가기 [Article Type] Review
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infectionArticle Published on 2022-09-302022-11-15 Journal: Journal of Antimicrobial Chemotherapy [Category] SARS, 치료제, [키워드] 95% CI adverse event antibody Antiviral effect ARMS clinical trial clinical trials control arm COVID-19 infection COVID-19 symptom criteria enrolled evaluated experimental arm Frequency had no healthcare worker high risk in vitro incidence rate Infection infection with SARS-CoV-2 nitazoxanide no significant difference participant PCR testing Poisson regression model positive SARS-CoV-2 PCR primary endpoint randomization Randomized randomized trial risk safety analysis SARS-CoV-2 SARS-COV-2 infection serology shown sofosbuvir/daclatasvir South Africa Symptoms the primary endpoint Treatment Trial was selected was used [DOI] 10.1093/jac/dkac266 PMC 바로가기
COVID-19 and diabetic ketoacidosis: A case series at an urban district hospital in South AfricaArticle Published on 2022-09-222022-11-16 Journal: South African Family Practice [Category] 치료기술, [키워드] Admission age appear biochemical Care case sery clinical outcomes Comorbidities Comorbidity Coronavirus disease 2019 COVID-19 COVID-19 infected patient COVID-19 infection detect diabetes Diabetic diabetic ketoacidosis district hospital. glycaemic control HbA1c hemoglobin HIV hospital Human immunodeficiency virus hypertension hypoxia hypoxic IMPROVE insulin male median age monotherapy Mortality Patient presenting Prevalence profiles ranged required risk factor South Africa study period the patient therapy type 2 diabete [DOI] 10.4102/safp.v64i1.5590 PMC 바로가기
Impact of Preexisting Anti-Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 VaccineArticle Published on 2022-09-212022-11-15 Journal: The Journal of Infectious Diseases [Category] SARS, 진단, 치료기술, [키워드] acute respiratory syndrome Ad26 Ad26.COV2.S Adenovirus Analysis antibody baseline Brazil coronavirus country COVID-19 Humoral immunity Immunity immunogenicity Impact participant Phase 3 postvaccination Preexisting immunity prevaccination recipient SARS-CoV-2 South Africa The United States Trial Vaccine vaccine-induced immune responses vaccine. [DOI] 10.1093/infdis/jiac142 PMC 바로가기
International risk of SARS-CoV-2 Omicron variant importations originating in South AfricaArticle Published on 2022-09-172022-11-16 Journal: Journal of Travel Medicine [Category] SARS, 변종, [키워드] country importations International introduced omicron raised reported risk SARS-CoV-2 SARS-CoV-2 variant South Africa spreading. variant World Health Organization [DOI] 10.1093/jtm/taac073 PMC 바로가기
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 InfectionArticle Published on 2022-09-142022-11-15 Journal: Journal of Virology [Category] SARS, 변종, 치료기술, [키워드] addition B.1 B.1.1.529 B.1.617.2 body temperature cats clinical COVID-19 D614G death Delta delta variant disease severity distribution effective Evidence evidenced histologic Hospitalization immunization immunofluorescence increased risk Infection infections Infectious virus Inflammation inoculated less lethargic log Lower lung Lung pathology Mild Model mutated nasal nasal turbinate observation omicron Pathogenesis pathogenic pathogenicity Pneumonia Postinfection present reduced remained Replication SARS-CoV-2 SARS-CoV-2 D614G SARS-CoV-2 variant secretion significant increase South Africa Spread staining suggested susceptible TCID tissue tissue tropism variant Variant of concern. variants Viral load viral replication Viral RNA viral titer Viral variants Virological virulence virus virus [DOI] 10.1128/jvi.00961-22 PMC 바로가기